Abstract
The Kaposi sarcoma herpesvirus (KSHV) encodes multiple proteins that disrupt host antiviral responses, including four viral proteins that have homology to the interferon regulatory factor (IRF) family of transcription factors. At least three of the KSHV vIRFs (vIRFs 1–3) alter responses to cellular IRFs and to interferons (IFNs), whereas functional changes resulting from the fourth vIRF (vIRF-4) have not been reported. The vIRFs also affect other important regulatory proteins in the cell, including responses to transforming growth factor β (TGF-β) and the tumor suppressor protein p53. This review examines the expression of the vIRFs during the life cycle of KSHV and the functional consequences of their expression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander L, Denekamp L, Knapp A, Auerbach MR, Damania B, Desrosiers RC (2000) The primary sequence of rhesus monkey rhadinovirus isolate 26–95: sequence similarities to Kaposi’s sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol 74:3388–3398
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732–738.
An FQ, Compitello N, Horwitz E, Sramkoski M, Knudsen ES, Renne R (2005) The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells fromp16 INK4A-induced cell cycle arrest. J Biol Chem 280:3862–3874
Ballestas ME, Chatis PA, Kaye KM (1999) Efficient persistence of extrachromosomal KSHVDNAmediated by latency-associated nuclear antigen. Science 284:641–644
Barnes B, Lubyova B, Pitha PM (2002) On the role of IRF in host defense. J Interferon Cytokine Res 22:59–71
Belanger C, Gravel A, Tomoiu A, Janelle ME, Gosselin J, Tremblay MJ, Flamand L (2001) Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol 4:62–73
Boshoff C, Weiss RA (1998) Kaposi’s sarcoma-associated herpesvirus. Adv Cancer Res 75:57–86
Brander C, Suscovich T, Lee Y, Nguyen PT, O’Connor P, Seebach J, Jones NG, van Gorder M, Walker BD, Scadden DT (2000) Impaired CTL recognition of cells latently infected with Kaposi’s sarcoma-associated herpes virus. J Immunol 165:2077–2083
Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R (2003) NF-κB inhibits gammaherpesvirus lytic replication. J Virol 77:8532–8540
Burysek L, Pitha PM (2001) Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–2352
Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, Pitha PM (1999a) Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334–7342
Burysek L, Yeow WS, Pitha PM (1999b) Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 2:19–32
Cannon M, Philpott NJ, Cesarman E (2003) The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol 77:57–67
Chan HM, La Thangue NB (2001) p300/CBP proteins:HATs for transcriptional bridges and scaffolds. J Cell Sci 114:2363–2373
Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237–249
Chen J, Ueda K, Sakakibara S, Okuno T, Yamanishi K (2000) Transcriptional regulation of the Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74:8623–8634
Clemens MJ (1997) PKR-a protein kinase regulated by double-stranded RNA. Int J Biochem Cell Biol 29:945–949
Clemens MJ, Elia A (1997) The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17:503–524.
Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali G, Hiscott J, Battistini A (1999) Activation and repression of the 2–5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene 18:2129–2137
Collot-Teixeira S, Bass J, Denis F, Ranger-Rogez S (2004) Human tumor suppressor p53 and DNA viruses. Rev Med Virol 14:301–319
Coscoy L, Ganem D (2000) Kaposi’s sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA
Cunningham C, Barnard S, Blackbourn DJ, Davison AJ (2003) Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol 84:1471–1483
D’Agostino G, Arico E, Santodonato L, Venditti M, Sestili P, Masuelli L, Coletti A, Modesti A, Picchio G, Mosier DE, Ferrantini M, Belardelli F (1999) Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res 19:1305–1316
Dittmer DP (2003) Transcription profile of Kaposi’s sarcoma-associated herpesvirus in primary Kaposi’s sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–2015
Donze O, Deng J, Curran J, Sladek R, Picard D, Sonenberg N (2004) The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 23:564–571
Dornan D, Eckert M, Wallace M, Shimizu H, Ramsay E, Hupp TR, Ball KL (2004) Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53. Mol Cell Biol 24:10083–10098
Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546–4551
Esteban M, Garcia MA, Domingo-Gil E, Arroyo J, Nombela C, Rivas C (2003) The latency protein LANA2 from Kaposi’s sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. J Gen Virol 84:1463–1470
Fakhari FD, Dittmer DP (2002) Charting latency transcripts in Kaposi’s sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 76:6213–6223
Feng XH, Derynck R (2005) Specificity and versatility in Tgf-β signaling through Smads. Annu Rev Cell Dev Biol 21:659–693
Flowers CC, Flowers SP, Nabel GJ (1998) Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-α. Mol Med 4:402–412
Floyd-Smith G, Wang Q, Sen GC (1999) Transcriptional induction of the p69 isoform of 2′,5′-oligoadenylate synthetase by interferon-β and interferon-γinvolves three regulatory elements and interferon-stimulated gene factor 3. Exp Cell Res 246:138–147
Friborg J, Jr., Kong W, Hottiger MO, Nabel GJ (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–894
Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS (1997) KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979–1985
Ghosh A, Sarkar SN, Rowe TM, Sen GC (2001) Aspecific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J Biol Chem 276:25447–25455.
Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G, Toomey NL, Shank NC, Cabral L, Barber GN, Harrington WJ, Jr. (2003) Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB. Blood 101:2321–2327
Guasparri I, Keller SA, Cesarman E (2004) KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993–1003
Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB (2004)Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways. J Biol Chem 279:15652–15661
Harcourt JL, Offermann MK (2001) Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-α-primed cells. Eur J Biochem 268:1373–1381.
Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899–2908
Hu J, Garber AC, Renne R (2002) The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76:11677–11687
Inagi R, Okuno T, Ito M, Chen J, Mori Y, Haque M, Zou P, Yagi H, Kiniwa S, Saida T, Ueyama Y, Hayashi K, Yamanishi K (1999) Identification and characterization of human herpesvirus 8 open reading frame K9 viral interferon regulatory factor by a monoclonal antibody. J Hum Virol 2:63–71
Jenner RG, Alba MM, Boshoff C, Kellam P (2001) Kaposi’s sarcoma-associated herpesvirus latent and lytic gene expressionas revealed by DNA arrays. J Virol 75:891–902
Jia Q, Chernishof V, Bortz E, McHardy I, Wu TT, Liao HI, Sun R (2005) Murine gammaherpesvirus 68 open reading frame 45 plays an essential role during the immediate-early phase of viral replication. J Virol 79:5129–5141
Justesen J, Hartmann R, Kjeldgaard NO (2000) Gene structure and function of the 2′–5′-oligoadenylate synthetase family. Cell Mol Life Sci 57:1593–1612.
Kaiser WJ, Kaufman JL, Offermann MK (2004) IFN-α sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 172:1699–1710
Kaiser WJ, Offermann MK (2005) Apoptosis Induced by the Toll-like receptor adaptor TRIF Is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 174:4942–4952
Keller SA, Schattner EJ, Cesarman E (2000) Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96:2537–2542
Klass CM, Krug LT, Pozharskaya VP, Offermann MK (2005) The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105:4028–4034
Kotenko SV, Pestka S (2000) Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19:2557–2565
Kreuz S, Siegmund D, Scheurich P, Wajant H (2001) NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21:3964–3973.
Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP (2002) Activities of IRF-1. J Interferon Cytokine Res 22:5–14
Krug LT, Pozharskaya VP, Yu Y, Inoue N, Offermann MK (2004) Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by αinterferon and phosphonoformic acid. J Virol 78:8359–8371
Lee SH, Kim JW, Lee HW, Cho YS, Oh SH, Kim YJ, Jung CH, Zhang W, Lee JH (2003) Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 22:381–391
Li M, Damania B, Alvarez X, Ogryzko V, Ozato K, Jung JU (2000) Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol 20:8254–8263
Li M, Lee H, Guo J, Neipel F, Fleckenstein B, Ozato K, Jung JU (1998) Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72:5433–5440
Li M, Shillinglaw W, Henzel WJ, Beg AA (2001) The Rela(p65) subunit of NF-кB is essential for inhibiting double-stranded RNA-induced cytotoxicity. J Biol Chem 276:1185–1194.
Lin R, Genin P, Mamane Y, Hiscott J (2000a) Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20:6342–6353
Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ, Jr., Barber GN, Hiscott J (2001) HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800–811
Lin R, Heylbroeck C, Pitha PM, Hiscott J (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986–2996
Lin R, Mamane Y, Hiscott J (2000b) Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem 275:34320–34327
Lubyova B, Kellum MJ, Frisancho AJ, Pitha PM (2004) Kaposi’s sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279:7643–7654
Lubyova B, Pitha PM (2000) Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74:8194–8201
Lukac DM, Renne R, Kirshner JR, Ganem D (1998) Reactivation of Kaposi’s sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304–312
Mak TW, Yeh WC (2002) Signaling for survival and apoptosis in the immune system. Arthritis Res 4Suppl 3: S243–252
Malmgaard L (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439–454
Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810
Matta H, Sun Q, Moses G, Chaudhary PM (2003) Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-κB activation. J Biol Chem 278:52406–52411
Means RE, Choi JK, Nakamura H, Chung YH, Ishido S, Jung JU (2002) Immune evasion strategies of Kaposi’s sarcoma-associated herpesvirus. Curr Top Microbiol Immunol 269:187–201
Meek DW (2004) The p53 response to DNA damage. DNA Repair (Amst) 3:1049–1056
Michalak E, Villunger A, Erlacher M, Strasser A (2005) Death squads enlisted by the tumour suppressor p53. Biochem Biophys Res Commun 331:786–798
Monini P, Carlini F, Sturzl M, Rimessi P, Superti F, Franco M, Melucci-Vigo G, Cafaro A, Goletti D, Sgadari C, Butto S, Leone P, Chiozzini C, Barresi C, Tinari A, Bonaccorsi A, Capobianchi MR, Giuliani M, di Carlo A, Andreoni M, Rezza G, Ensoli B (1999) Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol 73:4029–4041
Moore PS, Chang Y (2001) Molecular virology of Kaposi’s sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:499–516
Moore PS, Chang Y (2003) Kaposi’s sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 57:609–639
Morin P, Braganca J, Bandu MT, Lin R, Hiscott J, Doly J, Civas A (2002) Preferential binding sites for interferon regulatory factors 3 and 7 involved ininterferon-A gene transcription. J Mol Biol 316:1009–1022
Munoz-Fontela C, Rodriguez E, Nombela C, Arroyo J, Rivas C (2003) Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi’s sarcoma-associated herpesvirus. Biochem J 374:545–550
Nakamura H, Li M, Zarycki J, Jung JU (2001) Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75:7572–7582
Nakaya T, Sato M, Hata N, Asagiri M, Suemori H, Noguchi S, Tanaka N, Taniguchi T (2001) Gene induction pathways mediated by distinct IRFs during viral infection. Biochem Biophys Res Commun 283:1150–1156
Neipel F, Albrecht JC, Fleckenstein B (1997) Cell-homologous genes in the Kaposi’s sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71:4187–4192
O’Shea CC (2005) DNA tumor viruses—the spies who lyse us. Curr Opin Genet Dev 15:18–26
Offermann MK, Zimring J, Mellits KH, Hagan MK, Shaw R, Medford RM, Mathews MB, Goodbourn S, Jagus R (1995) Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I). poly (C) in endothelial cells. Eur J Biochem 232:28–36
Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10:431–442
Parekh BS, Maniatis T (1999) Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-β promoter. Mol Cell 3: 125–129
Park J, Seo T, Hwang S, Lee D, Gwack Y, Choe J (2000) The K-bZIP protein from Kaposi’s sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74:11977–11982
Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y (2000) Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Am J Pathol 156: 743–749
Pitha PM, Au WC, Lowther W, Juang YT, Schafer SL, Burysek L, Hiscott J, Moore PA (1998) Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. Biochimie 80:651–658
Pozharskaya VP, Weakland LL, Offermann MK (2004a) Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. J Gen Virol 85:2779–2787
Pozharskaya VP, Weakland LL, Zimring JC, Krug LT, Unger ER, Neisch A, Joshi H, Inoue N, Offermann MK (2004b) Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells. J Virol 78:6621–6635
Radkov SA, Kellam P, Boshoff C (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121–1127
Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF (1997) The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915–5921
Rebouillat D, Hovanessian AG (1999) The human 2′5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19:295–308
Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D (1996) Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2:342–346
Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y (2001) Kaposi’s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 75:429–438
Roan F, Inoue N, Offermann MK (2002) Activation of cellular and heterologous promoters by the human herpesvirus 8 replication and transcription activator. Virology 301:293–304.
Roan F, Zimring JC, Goodbourn S, Offermann MK (1999) Transcriptional activation by the human herpesvirus-8-encoded interferon regulatory factor. J Gen Virol 80 (Pt 8): 2205–2209
Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E (2002) IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22:39–47
Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93:14862–14867
Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778–809, table of contents.
Samuel CE, Kuhen KL, George CX, Ortega LG, Rende-Fournier R, Tanaka H (1997) The PKR protein kinase—an interferon-inducible regulator of cell growth and differentiation. Int J Hematol 65:227–237
Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS (1998) Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005–1012
Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y (1997) Kaposi’s sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Medi 3:293–298
Searles RP, Bergquam EP, Axthelm MK, Wong SW (1999) Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 73:3040–3053
Sengupta S, Harris CC (2005) p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6:44–55
Seo T, Lee D, Lee B, Chung JH, Choe J (2000) Viral interferon regulatory factor 1 of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem Biophys Res Commun 270:23–27
Seo T, Park J, Choe J (2005) Kaposi’s sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-β signaling. Cancer Res 65:1738–1747
Seo T, Park J, Lee D, Hwang SG, Choe J (2001) Viral interferon regulatory factor 1 of Kaposi’s sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol 75:6193–6198
Seo T, Park J, Lim C, Choe J (2004) Inhibition of nuclear factor кB activity by viral interferon regulatory factor 3 of Kaposi’s sarcoma-associated herpesvirus. Oncogene 23:6146–6155
Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J (2001) TGFβ in fluences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3:400–408
Servant MJ, Tenoever B, Lin R (2002) Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res 22:49–58
Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151
Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP, Wang XF (1998) TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 9:3309–3319
Slee EA, O’Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23:2809–2818
Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT (1997) Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71:715–719
Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J (1998) Nuclear factor (NF)-кB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J ExpMed 188:211–216
Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B (1999) Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst 91:1725–1733
Suhara W, Yoneyama M, Iwamura T, Yoshimura S, Tamura K, Namiki H, Aimoto S, Fujita T (2000) Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J Biochem (Tokyo) 128:301–307
Sun Q, Zachariah S, Chaudhary PM (2003) The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-кB activation. J Biol Chem 278:52437–52445
Tan SL, Katze MG (1999) The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J Interferon Cytokine Res 19:543–554.
Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623–655
Ueda K, Ishikawa K, Nishimura K, Sakakibara S, Do E, Yamanishi K (2002) Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism. J Virol 76:12044–12054
Vattem KM, Staschke KA, Wek RC (2001) Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2). Eur J Biochem 268:3674–3684
Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P, Ellis LM, Hung MC, Swisher SG, Hunt KK (2002) Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene 21:6278–6288.
Wang Q, Floyd-Smith G (1998) Maximal induction of p69 2′, 5′-oligoadenylate synthetase in Daudi cells requires cooperation between an ISRE and two IRF-1-like elements. Gene 222:83–90
Wang XP, Gao SJ (2003) Auto-activation of the transforming viral interferon regulatory factor encoded by Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 84:329–336
Waterston A, Bower M (2004) Fifty years of multicentric Castleman’s disease. Acta Oncol 43:698–704
Yang H, Lin CH, Ma G, Baffi MO, Wathelet MG (2003) Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J Biol Chem 278:15495–15504
Yang H, Lin CH, Ma G, Orr M, Baffi MO, Wathelet MG (2002) Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur J Biochem 269:6142–6151
Yang H, Ma G, Lin CH, Orr M, Wathelet MG (2004) Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter. Eur J Biochem 271:3693–3703
Yu F, Wang Q, Floyd-Smith G (1999) Transcriptional induction of p69 2′-5′-oligoadenylate synthetase by interferon-alpha is stimulated by 12-O-tetradecanoyl phorbol-13-acetate through IRF/ISRE binding motifs. Gene 237:177–184
Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ (2002) Efficient infection by a recombinant Kaposi’s sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76:6185–6196
Zhu FX, King SM, Smith EJ, Levy DE, Yuan Y (2002) A Kaposi’s sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci USA 99:5573–5578
Zhu FX, Yuan Y (2003) The ORF45 protein of Kaposi’s sarcoma-associated herpesvirus is associated with purified virions. J Virol 77:4221–4230
Zimring JC, Goodbourn S, Offermann MK (1998) Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701–707
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Offermann, M.K. (2007). Kaposi Sarcoma Herpesvirus-Encoded Interferon Regulator Factors. In: Boshoff, C., Weiss, R.A. (eds) Kaposi Sarcoma Herpesvirus: New Perspectives. Current Topics in Microbiology and Immunology, vol 312. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-34344-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-34344-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-34343-1
Online ISBN: 978-3-540-34344-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)